Human Papillomavirus (HPV) is a sexually transmitted infection that includes a group of related viruses. HPV infections are common, and while most cases resolve on their own, persistent infections can lead to various cancers, including cervical, anal, and oropharyngeal cancers. HPV vaccines, such as Gardasil and Cervarix, have been developed to protect against the most common high-risk HPV types. These vaccines are highly effective in preventing infection with certain HPV strains known to cause cancers and genital warts. Vaccination is recommended for both males and females, typically administered in adolescence before potential exposure to the virus. The vaccine's success has led to a reduction in HPV-related diseases, including a significant decrease in cervical pre-cancers and genital warts in vaccinated populations. Regular screenings, such as Pap smears and HPV tests, remain essential for early detection of HPV-related cancers. Education and awareness campaigns emphasize the importance of vaccination, screening, and safe sexual practices in reducing the overall burden of HPV infections and associated cancers. Ongoing research explores expanding vaccine coverage and addressing challenges related to global access and vaccine hesitancy.
Khursheed Nadeem Anwer
IMUNON, United States
Ping Xie
Rutgers University, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Ahmed Abdulazeez
BHRUT Trust, United KingdomSubmit your abstract Today
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey